ES2054975T3 - Composiciones antimalaricas que emplean quinidina, artemisinina y sus derivados. - Google Patents

Composiciones antimalaricas que emplean quinidina, artemisinina y sus derivados.

Info

Publication number
ES2054975T3
ES2054975T3 ES89118384T ES89118384T ES2054975T3 ES 2054975 T3 ES2054975 T3 ES 2054975T3 ES 89118384 T ES89118384 T ES 89118384T ES 89118384 T ES89118384 T ES 89118384T ES 2054975 T3 ES2054975 T3 ES 2054975T3
Authority
ES
Spain
Prior art keywords
antimalaric
artemisinin
quinidine
derivatives
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89118384T
Other languages
English (en)
Inventor
Deepak Kumar Dr Chatterjee
Bindumadhavan Dr Venugopalan
Jurgen Dr Blumbach
Subramani Natrajan Dr Iyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2054975T3 publication Critical patent/ES2054975T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

SE PRESENTA UN NUEVO COMPUESTO MEJORADO CONTRA LA MALARIA Y UN METODO DE TRATAMIENTO DE LA MISMA, QUE EMPLEA UNA COMBINACION CON, POR UN LADO, UNO DE LOS AGENTES ANTIMALARIALES ESCOGIDO ENTRE ARTEMISININA, DIHIDROARTEMISININA, ARTIDER, ARTEMEDER, ARTESUNATO Y POR OTRO LADO QUINIDINA Y OPCIONALMENTE MEFLOQUINA Y SUS SALES FARMACEUTICAMENTE ACEPTABLES.
ES89118384T 1988-10-07 1989-10-04 Composiciones antimalaricas que emplean quinidina, artemisinina y sus derivados. Expired - Lifetime ES2054975T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88116605 1988-10-07

Publications (1)

Publication Number Publication Date
ES2054975T3 true ES2054975T3 (es) 1994-08-16

Family

ID=8199431

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89118384T Expired - Lifetime ES2054975T3 (es) 1988-10-07 1989-10-04 Composiciones antimalaricas que emplean quinidina, artemisinina y sus derivados.

Country Status (10)

Country Link
EP (1) EP0362810B1 (es)
JP (1) JPH02157223A (es)
KR (1) KR900005978A (es)
CN (1) CN1041694A (es)
AU (1) AU4263789A (es)
DE (1) DE68906345T2 (es)
ES (1) ES2054975T3 (es)
MX (1) MX17877A (es)
NZ (1) NZ230926A (es)
ZA (1) ZA897618B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN166154B (es) * 1987-05-08 1990-03-24 Hoechst India
CN1058717A (zh) * 1990-08-08 1992-02-19 中国人民解放军军事医学科学院微生物流行病研究所 抗疟新药—复方蒿甲醚及其制备方法
US5637594A (en) * 1991-04-11 1997-06-10 Ciba Geigy Corporation Antimalarial synergistic compositions containing benflumetol
AU668376B2 (en) * 1992-02-07 1996-05-02 Novartis Ag Antimalarial synergistic compositions containing benflumetol
CH692321A5 (de) * 1997-11-03 2002-05-15 Mepha Ag Pharmazeutisch wirksame Zusammensetzung, welche eine gegen Malariaparasiten wirksame Substanz enthält.
CN1081035C (zh) * 1997-11-18 2002-03-20 广州市健桥医药科技发展有限公司 抗疟疾新药复方萘酚喹
CN1109546C (zh) * 1998-06-17 2003-05-28 中国疾病预防控制中心寄生虫病预防控制研究所 青蒿素类药物与咯萘啶的复方制剂抗疟药物
EP0974594A1 (en) * 1998-07-14 2000-01-26 The Hong Kong University of Science & Technology Artemisinin derivatives as anti-infective agent
AU2000255627A1 (en) * 2000-03-28 2001-10-08 Council Of Scientific And Industrial Research A novel anti-microbial composition and method for producing the same
EP1267864A1 (en) * 2000-03-31 2003-01-02 Council Of Scientific & Industrial Research A synergistic anti-malarial formulation
JPWO2002032905A1 (ja) * 2000-10-20 2004-02-26 味の素株式会社 マラリア治療のための医薬組成物、ドーズおよび方法
WO2003075927A1 (en) * 2002-02-13 2003-09-18 Mepha Ltd. Pharmaceutical combination of artesunate and mefloquine for therapy of malaria
WO2005023304A2 (en) * 2003-09-04 2005-03-17 Cipla Limited Antimalarial compositions and manufacturing process thereof
BRPI0401107A (pt) * 2004-04-13 2005-11-22 Fundacao Oswaldo Cruz Compostos derivados de artesunato, processo de preparação destes compostos, composição farmacêutica contendo os ditos compostos, uso do respectivo medicamento no tratamento ou prevenção da malária ou outras doenças parasitárias e método terapêutico
CH700941B1 (de) * 2007-12-04 2010-11-15 Mepha Ag Pharmazeutische Zusammensetzung zur Behandlung von Malaria.
WO2013095215A1 (en) * 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
EP2929881A1 (en) * 2014-04-11 2015-10-14 CeMM - Forschungszentrum für Molekulare Medizin GmbH Medical use of artemisinin compounds and gephyrin agonists
CN110691597A (zh) 2017-04-24 2020-01-14 诺华股份有限公司 2-氨基-1-(2-(4-氟苯基)-3-(4-氟苯基氨基)-8,8-二甲基-5,6-二氢咪唑并[1,2-a]吡嗪-7(8H)-基)乙酮及其组合的治疗方案
EP4444417A4 (en) * 2021-12-09 2026-02-11 Incarda Therapeutics Inc INHALATED THERAPY FOR CARDIAC ARRHYTHMIA

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN166154B (es) * 1987-05-08 1990-03-24 Hoechst India

Also Published As

Publication number Publication date
NZ230926A (en) 1992-02-25
CN1041694A (zh) 1990-05-02
MX17877A (es) 1993-11-01
ZA897618B (en) 1990-06-27
DE68906345T2 (de) 1993-10-28
DE68906345D1 (de) 1993-06-09
JPH02157223A (ja) 1990-06-18
EP0362810A1 (en) 1990-04-11
KR900005978A (ko) 1990-05-07
EP0362810B1 (en) 1993-05-05
AU4263789A (en) 1990-04-12

Similar Documents

Publication Publication Date Title
ES2054975T3 (es) Composiciones antimalaricas que emplean quinidina, artemisinina y sus derivados.
ES2170102T3 (es) Aminociclohexilesteres y utilizacion de los mismos.
MX9405219A (es) Nueva formulacion farmaceutica.
ES2053778T3 (es) Procedimiento para la obtencion de derivados del tiazol.
ES2145318T3 (es) Imidazo(4,5-c)quinolin-aminas.
FR2599961B1 (fr) Piece a main medicale a laser.
NO893834L (no) Terapeutiske forbindelser for aids basert paa hemmere av hiv-protease.
DK249389D0 (da) 2-acylamino-benzothiazol-forbindelser og deres anvendelse til fremstilling af laegemidler til behandling af tumorer
IT8567521A1 (it) Apparecchiatura e procedimento per rilevare le variazioni, nel tempo, di caratteristiche di una zona o dell'insieme di una persona, ed applicazioni del procedimento.
ES2093650T3 (es) Una solucion farmaceutica que comprende derivados de fk506.
ES557836A0 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene 3'-azido-3'-desoxitimidina o uno de sus derivados farmaceuticamente aceptables.
MX9300662A (es) Derivados fosfonooxi y carbonato de taxol
NO883168L (no) Fremgangsmaate for aa bestemme fallet og retningen av en formajonsfraktur som skjaerer et borehull.
ES2067874T3 (es) Derivados de acetamida.
ES2066998T3 (es) Accesorio medico.
LU88822I2 (fr) Stavudine et ses dérivés pharmaceutiquement acceptables (Zerit R)
ES2063186T3 (es) Derivados ftalinida, composicion farmaceutica y uso.
ES2159362T3 (es) Utilizacion de la 1-(2-naft-2-iletil)-4-(3-trifluorometilfenil)-1,2,3,6-tetrahidropiridina para la preparacion de medicamentos destinados para el tratamiento de la esclerosis lateral amiotrofica.
NO960775L (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
FR2421614A1 (fr) Composition pharmaceutique a base de 2-(7'-theophyllinomethyl)-1,3-dioxolane
NO860732L (no) N-(2-klor-4-nitrofenyl)-benzensulfonamidderivat, fremgangsmaate for fremstilling av dette, og fungicid middel inneholdende dette.
DK0458589T3 (da) Behandling af okulær hypertension med en okulær synergistisk kombination
FI893111L (fi) Benzotiazindioxidderivat.
ES1001159Y (es) Muneco perfeccionado con mecanismo de voz, combinado con el accionamiento de boca y ojos
DE3879985D1 (de) Anticonvulsive agenzien.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 362810

Country of ref document: ES